Atlas FDA

SYNVISC ONE

FDA premarket approval P940015/S040 · decided 2017-05-11

Approval details

PMA number
P940015
Supplement
S040
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
SYNVISC ONE
Generic name
Acid, hyaluronic, intraarticular
Applicant
Sanofi Genzyme Corp.
Date received
2017-04-17
Decision date
2017-05-11
Days to decision
24 days
Decision code
OK30
Product code
MOZ
Advisory committee
Orthopedic
Expedited review
No
Location
Cambridge, MA
Statement
Modifications to the sterilization process of a component used to manufacture Synvisc and Synvisc-One.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.